Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Occupational asthma in office workers.

Occupational medicine (Oxford, England)·2022
Same author

Occupational asthma caused by peracetic acid-hydrogen peroxide mixture.

Occupational medicine (Oxford, England)·2019
Same author

Cleaning agent occupational asthma in the West Midlands, UK: 2000-16.

Occupational medicine (Oxford, England)·2018
Same author

Asbestosis is prevalent in a variety of construction industry trades.

NPJ primary care respiratory medicine·2018
Same author

Occupational asthma caused by acrylic compounds from SHIELD surveillance (1989-2014).

Occupational medicine (Oxford, England)·2017
Same author

Biopsy-proven hypersensitivity pneumonitis caused by a fluorocarbon waterproofing spray.

Occupational medicine (Oxford, England)·2017

相关实验视频

Updated: Jul 27, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

伪多细胞血症的发病率和死亡率.

P S Burge, W S Johnson, T A Prankerd

    Lancet (London, England)
    |June 7, 1975
    PubMed
    概括

    伪多聚细胞血症是一种导致高密集细胞体积的疾病,其死亡率比以前认为的要高. 这项研究表明,对患有这种血液疾病的患者的预后进行了修订.

    科学领域:

    • 血液学 血液学 血液学
    • 临床医学 临床医学
    • 内部医学 内部医学

    背景情况:

    • 伪多聚细胞血症通常被认为是一种良性疾病,预后良好.
    • 以前的研究还没有完全阐明与伪多细胞血症相关的长期结果和死亡率.

    研究的目的:

    • 为了调查被诊断为伪多细胞血病的患者的长期临床过程和死亡率.
    • 在经验数据的基础上重新评估伪多细胞血病的普遍接受的预后.

    主要方法:

    • 对35名被诊断患有伪多细胞血症的患者进行了一项随访研究.
    • 监测了关键的临床参数,包括症状,包装细胞体积和血体积.
    • 患者组内的死亡率与一般人群预期的死亡率进行了比较.

    主要成果:

    • 在大多数伪多细胞血症患者中观察到持续的症状,增加的包装细胞体积和减少的血体积.
    • 在这些患者中观察到的死亡率是预期的6倍.
    • 这些发现表明预后远比通常认为的差得多.

    结论:

    • 伪多细胞血症的预后需要修订,因为这种情况与死亡率大幅增加有关.

    更多相关视频

    Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
    08:23

    Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

    Published on: November 5, 2019

    A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
    08:53

    A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

    Published on: January 10, 2025

    相关实验视频

    Last Updated: Jul 27, 2026

    Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
    09:40

    Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

    Published on: January 19, 2017

    Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
    08:23

    Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

    Published on: November 5, 2019

    A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
    08:53

    A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

    Published on: January 10, 2025

  • 临床医生应该意识到增加的风险,并可能重新评估伪多细胞血症患者的管理策略.